Key result
Bioadaptor implantation maintains ~100% vessel patency at 6 months in severely calcified coronary lesions.
Why the study?
Calcified coronary lesions remain challenging in PCI because of their morphological complexity, and restoring physiological vasomotion and vascular remodeling is an emerging goal while bioadaptor use in heavily calcified lesions had not previously been reported.
Does implantation of a sirolimus-eluting cobalt-chromium bioadaptor result in sustained vessel patency at 6 months in patients with severely calcified coronary lesions?
Case Report (n=3)
Does implantation of a sirolimus-eluting cobalt-chromium bioadaptor result in sustained vessel patency at 6 months in patients with severely calcified coronary lesions?
In this first case series of 3 patients, bioadaptor implantation in severely calcified coronary lesions was feasible and demonstrated sustained vessel patency at 6 months following aggressive lesion preparation.
May support bioadaptor use after atherectomy in calcified PCI; leaves open confirmation of vasomotion benefits in prospective trials.
BACKGROUND: Calcified coronary lesions remain among the most challenging subsets in percutaneous coronary intervention (PCI) because of their morphological complexity. Restoring physiological vasomotion and vascular remodeling is an emerging goal in PCI. CASE SUMMARY: We present 3 patients with severely calcified coronary lesions treated with PCI. Lesion preparation included rotational atherectomy was performed in 2 of 3 cases, followed by implantation of a bioadaptor-a sirolimus-eluting cobalt-chromium hybrid stent system. In 1 case, a super high-pressure OPN balloon was used for postdilatation. Six-month follow-up angiography showed favorable outcomes with sustained vessel patency in all cases. DISCUSSION: This is the first case series reporting bioadaptor use in heavily calcified coronary lesions. Adequate lesion preparation is essential for procedural success and clinical outcomes. TAKE-HOME MESSAGES: In this case series, bioadaptor implantation in severely calcified coronary lesions was feasible, with favorable short-term outcomes at 6 months. In calcified lesions, more aggressive lesion preparation than for conventional drug-eluting stents may be required, as adequate calcium modification is a prerequisite for full device expansion and for realizing the bioadaptor's long-term functional benefits after uncaging.
No takes yet. Share an insight, caveat, or question.
Amoey et al. (2026) conducted a case report in Severely calcified coronary lesions (n=3). Sirolimus-eluting cobalt-chromium bioadaptor was evaluated on Angiographic vessel patency at 6 months.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: